SREBF1 and fatty liver disease: The induction of pathogenesis of hepatic steatosis by HBV is mediated by the sterol regulatory element binding protein 1 (SREBP-1) and the peroxisome proliferator-activated receptor (PPAR) [6], resulting in transcriptional activation via the PI3K/AKT/PTEN pathway or by protein–protein interactions.